SAMANTIA WRIGHT: Open Payments
NPI 1457897076 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 38 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $155 · 2025 $861
Food & beverage: $751Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $241 |
| ABBVIE INC. | 12 | $141 |
| Lundbeck LLC | 8 | $138 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Eisai Inc. | 1 | $15 |
Products named: REXULTI, VRAYLAR, AUSTEDO XR, BREZTRI, TRINTELLIX, INGREZZA, Leqembi, QULIPTA.
Industry payments across NJ — which companies pay providers there.
